Effects of opioid antagonists and their quaternary analogs on temperature changes in morphine-dependent rats.
Subcutaneous administration of three opioid antagonists; naloxone, naltrexone and nalmefene, produced a significant rise in tail skin temperature and a subsequent fall in rectal temperature in morphine dependent rats. However, subcutaneous administration of equimolar concentrations of the quaternary derivatives of these opioid antagonists (naloxone methobromide, naltrexone methobromide and n-methylnalmefenium iodide) failed to produce any significant alterations in either tail skin or rectal temperatures in the morphine dependent rat. At doses of naloxone methobromide 6 to 9 times greater than naloxone, there was a slight reduction of rectal temperatures with no significant elevation of skin temperature. However, the fall in rectal temperature was still significantly less than that achieved with administration of naloxone. When each of these six agents were administered centrally (20 micrograms/5 microliter, icv) in the morphine dependent rat, similar increases in tail skin temperature and decreases in rectal temperature were observed. These temperature changes were similar to those observed following systemic administration of the opioid antagonist. Previously, we have suggested that acute withdrawal in the morphine-dependent rat may serve as an animal model for the mechanism of the menopausal hot flush. Collectively, these results suggest that the temperature changes associated with morphine-withdrawal in our rat model for studying the mechanisms of the menopausal hot flush are centrally mediated.
D000818:Animals; D001812:Blood-Brain Barrier; D001833:Body Temperature Regulation / Q000187:drug effects*; D001921:Brain / Q000187:drug effects; D002979:Climacteric / Q000187:drug effects / Q000502:physiology*; D005260:Female; D009021:Morphine Dependence / Q000503:physiopathology*; D009292:Narcotic Antagonists / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D012881:Skin Temperature / Q000187:drug effects
D009292:Narcotic Antagonists